Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from OptiBiotix Health ( (GB:OPTI) ).
OptiBiotix Health plc has announced the launch of its SlimBiome® products with Natural Health Trends Corp, a NASDAQ-listed company. This collaboration marks the introduction of TwinSlim Tomato Soup, a product designed to reduce hunger and food cravings, in Hong Kong for the Chinese market, with plans for a US launch. The partnership is part of OptiBiotix’s strategy to expand its presence in high-growth markets like Asia and the USA, leveraging its clinically proven products. The company is seeing increased interest from large partners globally, driven by the rising demand for natural alternatives to anti-obesity drugs, and aims to enhance brand recognition and achieve profitability through regular product launches and repeat orders.
More about OptiBiotix Health
OptiBiotix Health plc is a life sciences company focused on developing products that modify the human microbiome to prevent and manage diseases and promote wellness. The company, formed in 2012, engages in extensive R&D, collaborating with leading academics to create microbial strains and formulations used in food and healthcare supplements. OptiBiotix’s focus areas include obesity, cardiovascular health, and diabetes, and it has partnerships with over twenty international companies to incorporate its microbiome modulators into various products.
Average Trading Volume: 274,224
Technical Sentiment Signal: Sell
Current Market Cap: £17.87M
Learn more about OPTI stock on TipRanks’ Stock Analysis page.